Jakob Dupont Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jakob Dupont.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jakob Dupont. Jakob Dupont is a SVP & Chief Medical Officer in OncoMed Pharmaceuticals Inc ($OMED) and a EVP, Head of R&D in Atara Biotherapeutics, Inc. ($ATRA) and a Chief Medical Officer in Gossamer Bio, Inc. ($GOSS).
Address: C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY 94063 CA
Companies in which Jakob Dupont is an Insider
Atara Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jakob Dupont: EVP, Head of R&D
Holdings: 100,129 shares
Current Value: $1,506,941
Latest Transaction: Mar 03 2021
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gossamer Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jakob Dupont: Chief Medical Officer
Holdings: 46,500 shares
Latest Transaction: Feb 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoMed Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jakob Dupont: SVP & Chief Medical Officer
Holdings: 34,440 shares
Current Value: $281,719
Latest Transaction: Oct 11 2016
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jakob Dupont
Sentiment: All, ATRA, GOSS, OMED
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 17.11 | 81,327 | 1,391,098 | 81,327 | |
| Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 53,879 | 0 | 100,129 | 46.3 K to 100.1 K (+116.50 %) |
| May 19 2020 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 9.58 | 277,500 | 2,658,450 | 277,500 | |
| May 19 2020 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 46,250 | 0 | 46,250 | 0 to 46.3 K |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | A | 14.55 | 71,500 | 1,040,325 | 71,500 | |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Grant | A | 0.00 | 46,500 | 0 | 46,500 | 0 to 46.5 K |
| Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | M | 10.71 | 40,000 | 428,400 | 439,317 |